FIELD: medicine, oncology.
SUBSTANCE: the present innovation deals with treating oncological diseases, local and invasive forms of uterine cervix cancer, in particular. The method deals with local application of inductors of endogenic interferon in preoperational period. One should daily perform 14 applications with 5%-cycloferon liniment onto a tumor at the volume of 3-5 ml either in caps or at tampons during 2 wk at the background of distance radiation therapy at the dosage of 20-30 g/small pelvis. Then patients should undergo radical hysterectomy. The method enables to reduce tumor size, increase its operability and survival rate in patients due to activation of own immunity and possible radio-sensitizing impact of cycloferon upon a tumor.
EFFECT: higher efficiency of therapy.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING UTERINE NECK CARCINOMA OF IB2β-III STAGE | 2000 |
|
RU2174020C1 |
METHOD FOR TREATING ONCOLOGICAL PATIENTS WITH VAGINAL TUMOR LESION | 2004 |
|
RU2268724C1 |
RETROGRADE RADICAL HYSTERECTOMY TECHNIQUE | 2008 |
|
RU2381010C2 |
METHOD FOR PREPARING UTERINE NECK CARCINOMA PATIENTS OF THE III STAGE FOR MAKING OPERATION | 1996 |
|
RU2149661C1 |
METHOD OF TREATING CERVICAL CANCER | 2011 |
|
RU2454256C1 |
METHODS OF TREATING PATIENTS WITH LOCALLY ADVANCED UTERINE CANCER | 2013 |
|
RU2514342C1 |
COMBINED METHOD FOR TREATING THE CASES OF III A, B STAGE UTERINE NECK CANCER IN YOUNG WOMEN | 1998 |
|
RU2163786C2 |
METHOD FOR TREATING LOCAL RELAPSES OF UTERINE CERVICAL CANCER | 2003 |
|
RU2240114C1 |
METHOD FOR COMBINED ORGAN-PRESERVING TREATMENT OF INVASIVE CERVICAL CANCER STAGE IB-II | 2020 |
|
RU2748904C1 |
METHOD FOR COMBINED TREATMENT OF LOCALLY ADVANCED FORMS OF CERVICAL CANCER IIB-IIIB (T2B-T3BN0(1)M0) STAGES | 2020 |
|
RU2748135C2 |
Authors
Dates
2004-07-20—Published
2002-08-12—Filed